Growth Metrics

DBV Technologies (DBVT) Total Non-Current Liabilities (2014 - 2026)

DBV Technologies (DBVT) reported Total Non-Current Liabilities of $6.7 million for Q1 2026, down 8.28% year-over-year from $7.3 million in Q1 2025, and down 2.9% on a QoQ basis from $6.9 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Total Non-Current Liabilities data on file, last reported at $6.7 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 8.28% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 8.28% YoY) and the FY2025 annual result came in at $6.9 million, down 3.29% from the prior year.
  • Total Non-Current Liabilities eased to $6.7 million in Q1 2026 per DBVT's latest filing, from $6.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $22.5 million in Q4 2022 and bottomed at $5.5 million in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $7.8 million (2025), against an average of $10.5 million.
  • Peak annual rise in Total Non-Current Liabilities reached 121.92% in 2023, while the deepest fall reached 75.78% in 2023.
  • Tracing DBVT's Total Non-Current Liabilities over 5 years: stood at $22.5 million in 2022, then slumped by 75.78% to $5.5 million in 2023, then soared by 30.65% to $7.1 million in 2024, then retreated by 3.29% to $6.9 million in 2025, then retreated by 2.9% to $6.7 million in 2026.
  • Per Business Quant, the three latest DBVT Total Non-Current Liabilities figures stand at $6.7 million (Q1 2026), $6.9 million (Q4 2025), and $8.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 6.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.70 Mn
Dec 31, 2025 6.90 Mn
Sep 30, 2025 8.16 Mn
Jun 30, 2025 7.78 Mn
Mar 31, 2025 7.31 Mn
Dec 31, 2024 7.14 Mn
Sep 30, 2024 8.11 Mn
Jun 30, 2024 7.71 Mn
Mar 31, 2024 7.76 Mn
Dec 31, 2023 5.46 Mn
Sep 30, 2023 14.35 Mn
Jun 30, 2023 19.91 Mn
Mar 31, 2023 21.06 Mn
Dec 31, 2022 22.54 Mn
Sep 30, 2022 7.67 Mn
Jun 30, 2022 10.13 Mn
Mar 31, 2022 9.49 Mn
Dec 31, 2021 16.05 Mn
Sep 30, 2021 20.22 Mn
Jun 30, 2021 18.87 Mn
Mar 31, 2021 13.40 Mn
Dec 31, 2020 14.04 Mn
Jun 30, 2020 21.83 Mn
Dec 31, 2019 24.18 Mn
Sep 30, 2019 26.79 Mn
Jun 30, 2019 27.57 Mn
Dec 31, 2018 7.90 Mn
Jun 30, 2018 12.44 Mn
Dec 31, 2017 14.08 Mn
Jun 30, 2017 15.09 Mn
Dec 31, 2016 16.90 Mn
Jun 30, 2016 14.74 Mn
Dec 31, 2015 5.68 Mn
Jun 30, 2015 6.03 Mn
Dec 31, 2014 5.52 Mn